12:00 AM
 | 
Feb 05, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Neurofibromin 1 (NF1)

Cancer

INDICATION: Neurofibromatosis

Mouse studies suggest MEK inhibitors could help treat neurofibromatosis type 1, which is caused by loss-of-function mutations in the tumor suppressor gene NF1. In neonatal mice with neuronal...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >